Order Article Reprints

Doniec Z, Olszanecka-Glinianowicz M, Hantulik P, Almgren-Rachtan A, Chudek J. The Efficacy, Tolerance and Acceptance of a New Fixed-Dose Salmeterol and Fluticasone Propionate Dry-Powder Inhaler—Salflumix Easyhaler^® in COPD Patients in the Daily Clinical Practice. Applied Sciences. 2022; 12(23):12142. https://doi.org/10.3390/app122312142

Doniec, Zbigniew, Magdalena Olszanecka-Glinianowicz, Piotr Hantulik, Agnieszka Almgren-Rachtan, and Jerzy Chudek. 2022. "The Efficacy, Tolerance and Acceptance of a New Fixed-Dose Salmeterol and Fluticasone Propionate Dry-Powder Inhaler—Salflumix Easyhaler^® in COPD Patients in the Daily Clinical Practice" Applied Sciences 12, no. 23: 12142. https://doi.org/10.3390/app122312142

Doniec, Z., Olszanecka-Glinianowicz, M., Hantulik, P., Almgren-Rachtan, A., & Chudek, J. (2022). The Efficacy, Tolerance and Acceptance of a New Fixed-Dose Salmeterol and Fluticasone Propionate Dry-Powder Inhaler—Salflumix Easyhaler^® in COPD Patients in the Daily Clinical Practice. Applied Sciences, 12(23), 12142. https://doi.org/10.3390/app122312142